Many hospitals now treat surgery as more than a single procedure. Increasingly, it has become an opportunity to uncover hidden health conditions that may otherwise go undetected for years. One important trend is perioperative diabetes screening, which helps health systems identify patients with undiagnosed diabetes and prediabetes before surgery begins. …
Read More »Diabetes and Hearing Loss: The Complication Many Clinicians Still Miss
Diabetes-related complications often bring to mind kidney disease, neuropathy, or vision problems. However, one complication continues to receive far less attention despite growing scientific concern: hearing loss linked to diabetes. Emerging evidence suggests that people with diabetes may face a significantly higher risk of hearing decline, yet routine auditory screening …
Read More »Smart Insoles and AI Foot Monitoring: Could Diabetes Foot Care Finally Become Preventive?
For many people living with diabetes, foot complications often begin quietly. A small pressure point, unnoticed inflammation, or minor skin breakdown can slowly develop into a serious ulcer. Unfortunately, traditional diabetic foot care has long been reactive. Clinicians typically intervene after visible wounds appear, when treatment becomes more difficult and …
Read More »Are Wearables Redefining Prediabetes — or Over-Medicalizing It?
Prediabetes has traditionally been diagnosed during annual physical exams through fasting glucose tests or A1C measurements. However, new diabetes prevention tools and wearable technologies are rapidly changing that model. Today, wearable devices, continuous glucose monitors (CGMs), and predictive metabolic tracking tools are giving people real-time insight into their glucose patterns …
Read More »Can AI Eye Exams Expand Diabetic Retinopathy Screening Access?
Diabetic retinopathy remains one of the leading causes of preventable blindness worldwide. Yet despite clear screening guidelines, many patients with diabetes still miss their annual retinal exams. Busy schedules, limited specialist access, transportation barriers, and lack of awareness often delay diagnosis until vision changes become permanent. As healthcare systems search …
Read More »The Diabetes Diagnosis Gap: Are We Missing Patients Who Don’t Fit Classic Risk Profiles?
Diabetes screening has improved over the last two decades, yet many patients still fall through the cracks. While clinicians often rely on traditional risk models that focus on obesity, age, family history, and sedentary lifestyle, not every patient with diabetes fits that familiar picture. As a result, many diabetes cases …
Read More »Early-Onset Type 2 Diabetes: Why Younger Patients Face Higher Lifetime Risk
Early onset type 2 diabetes is no longer rare, and its rise among younger adults raises serious concerns. What happens when a chronic condition that typically appears later in life begins decades earlier? Much like starting a marathon with added weight, younger patients face a longer disease course and a …
Read More »GLP-1s and Serious Mental Illness: Tackling Antipsychotic-Associated Weight Gain
For many patients, antipsychotic medications are life-changing, even life-saving. Yet the same treatments that stabilize mood and thought can quietly drive weight gain, insulin resistance, and rising cardiometabolic risk. Over time, this unintended consequence places patients with serious mental illness at a much higher risk for obesity, type 2 diabetes, …
Read More »Prescribing GLP‑1s for Obesity Without Diabetes: How to Treat “Normoglycemic” Risk
In recent years, GLP‑1-based treatments for obesity have evolved from being primarily a diabetes-focused strategy to becoming a powerful tool for managing weight and reducing cardiometabolic risk—especially in individuals without type 2 diabetes. This growing trend is shifting how clinicians identify and manage obesity, moving beyond A1C levels to a …
Read More »Reframing Prediabetes: Can Structured Lifestyle Programs Delay or Avoid Medication Use?
Prediabetes affects a striking proportion of adults worldwide, creating a crucial window for intervention before type 2 diabetes develops. While medications like metformin are frequently considered for high-risk individuals, evidence from large clinical trials shows that lifestyle-based strategies — especially the National Diabetes Prevention Program — can dramatically reduce the …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.